UCLA and UCSF doctors fought HIV from its earliest beginnings. Now, they are beginning to speak of a cure.

A synthetic particle can awaken dormant virus cells and knock them out in lab animals — a significant advance.

Spurred by three decades of momentum and fresh funding, new tactics aim at ending - not just treating - the disease.

New system to be tested this summer could transform HIV treatment in low-resource settings.

A new study shows that effective treatment of patients in Denmark has virtually contained the disease.

UCSF lends its support to a new documentary about the challenges facing eight long-term survivors of AIDS.

A two- or three-drug combination given to infants of HIV-positive mothers within 48 hours of birth cut infection rates to half of what was achieved with AZT alone.

Study of simian immunodeficiency virus yields insight into varied reaction to virus in humans.

Researchers found that gay and bisexual black and Latino men voluntarily used health-related Facebook groups.

UCSF AIDS pioneer continues to uncover the biological mysteries of the virus that has defined a generation.

The longer life expectancy of those infected with HIV presents a new challenge for patients and health care providers.